Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Apple
AAPL
|
+$391M |
| 2 |
Amazon
AMZN
|
+$361M |
| 3 |
Microsoft
MSFT
|
+$358M |
| 4 |
Meta Platforms (Facebook)
META
|
+$196M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$171M |
Top Sells
| 1 |
Alibaba
BABA
|
+$1.07B |
| 2 |
Newmont
NEM
|
+$141M |
| 3 |
Eli Lilly
LLY
|
+$125M |
| 4 |
Waste Management
WM
|
+$124M |
| 5 |
McDonald's
MCD
|
+$112M |
Sector Composition
| 1 | Technology | 27.15% |
| 2 | Healthcare | 14.17% |
| 3 | Consumer Discretionary | 13.28% |
| 4 | Communication Services | 11.57% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
LMNX
1701
DELISTED
Luminex Corp
LMNX
| $3.78M | ﹤0.01% |
102,600
+1,600
| +2% | +$58.9K |
|
1702
M/I Homes
MHO
$4.07B
| $3.77M | ﹤0.01% |
64,200
-1,500
| -2% | -$88K |
|
|
ILPT
1703
Industrial Logistics Properties Trust
ILPT
$424M
| $3.76M | ﹤0.01% |
143,947
-5,200
| -3% | -$136K |
|
|
TRQ
1704
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $3.76M | ﹤0.01% |
222,610
-6,700
| -3% | -$113K |
|
1705
JFrog
FROG
$5.83B
| $3.75M | ﹤0.01% |
+82,400
| New | +$3.75M |
|
1706
Community Health Systems
CYH
$412M
| $3.75M | ﹤0.01% |
242,826
+37,900
| +18% | +$585K |
|
|
MTOR
1707
DELISTED
MERITOR, Inc.
MTOR
| $3.75M | ﹤0.01% |
159,900
+3,000
| +2% | +$70.3K |
|
1708
Adtalem Global Education
ATGE
$4.94B
| $3.74M | ﹤0.01% |
105,000
-14,100
| -12% | -$502K |
|
|
CRON
1709
Cronos Group
CRON
$969M
| $3.74M | ﹤0.01% |
433,400
-16,500
| -4% | -$142K |
|
1710
nCino
NCNO
$3.48B
| $3.74M | ﹤0.01% |
+62,400
| New | +$3.74M |
|
|
CGAU
1711
Centerra Gold
CGAU
$1.88B
| $3.73M | ﹤0.01% |
+490,900
| New | +$3.73M |
|
|
ADAM
1712
Adamas Trust, Inc. Common Stock
ADAM
$644M
| $3.72M | ﹤0.01% |
208,155
-7,625
| -4% | -$136K |
|
|
EPAY
1713
DELISTED
Bottomline Technologies Inc
EPAY
| $3.68M | ﹤0.01% |
99,200
-3,900
| -4% | -$145K |
|
1714
Oxford Industries
OXM
$704M
| $3.68M | ﹤0.01% |
37,200
-1,400
| -4% | -$138K |
|
1715
Quanterix
QTRX
$224M
| $3.66M | ﹤0.01% |
62,400
-2,000
| -3% | -$117K |
|
1716
Global Net Lease
GNL
$1.81B
| $3.66M | ﹤0.01% |
197,567
-6,900
| -3% | -$128K |
|
1717
ICF International
ICFI
$1.83B
| $3.66M | ﹤0.01% |
41,600
-1,500
| -3% | -$132K |
|
1718
Establishment Labs
ESTA
$1.09B
| $3.65M | ﹤0.01% |
+41,800
| New | +$3.65M |
|
1719
BGC Group
BGC
$4.82B
| $3.63M | ﹤0.01% |
640,808
-10,500
| -2% | -$59.5K |
|
1720
Northwest Bancshares
NWBI
$1.83B
| $3.63M | ﹤0.01% |
266,000
-11,400
| -4% | -$155K |
|
1721
ADT
ADT
$7.24B
| $3.62M | ﹤0.01% |
335,900
-11,900
| -3% | -$128K |
|
1722
Axsome Therapeutics
AXSM
$5.91B
| $3.61M | ﹤0.01% |
53,500
-10,500
| -16% | -$708K |
|
|
POLY
1723
DELISTED
Plantronics, Inc.
POLY
| $3.61M | ﹤0.01% |
86,400
+1,600
| +2% | +$66.8K |
|
1724
Seres Therapeutics
MCRB
$139M
| $3.6M | ﹤0.01% |
7,540
+245
| +3% | +$117K |
|
1725
Supernus Pharmaceuticals
SUPN
$2.55B
| $3.58M | ﹤0.01% |
116,100
-4,300
| -4% | -$132K |
|